Lonza reports revenues of 6.7 billion Swiss francs, CER growth of 10.9%1 , and CORE EBITDA of 2 billion Swiss francs, establishing a margin of 29.8%. At the same time, the appointment of Jean-Marc Huët to succeed Albert M. Baehny as President of the company is made official. Albert M. Baehny, Chairman of the Board
Solid financial 2023 results for Lonza, with investments in Visp ! Read More »
Stämm, an innovative leader in bioprocessing technology, has announced the opening of its new R&D facility at the technological site of BioArk in Monthey. With the establishment of its new R&D facility in Valais(Switzerland), Stämm is set to bring its pioneering technology to the heart of Europe’s thriving biotech sector. The new facility at BioArk
BioArk Monthey welcomes the new R&D center of Stämm ! Read More »
As head of start-up ImmunSkills, based at our BioArk Monthey technology site, Adolfo Gonzalez has propelled the company to notable achievements in the field of cell-based therapy. Through our interview with its CEO, discover how ImmunSkills is transforming cancer treatment by introducing revolutionary methods and therapeutic advances designed to offer more accessible and effective treatments
ImmunSkills transforms cell therapy for cancer treatment Read More »
Win your place in the Swiss National Startup Team 2024 & Meet industry leaders and international biotech investors on an exclusive roadshow in Boston ! We are excited to launch this year’s call for the most promising startups in biotechnology, to showcase their innovation to investors and corporates in Boston. Application deadline : Feb.26, 2024
Application process for Venture Leaders Biotech 2024 is now open Read More »
MINTworld is the result of a collaboration between Lonza and the Department of Economy and Education (DEF) of the Canton of Valais. The aim of this discovery and innovation center in Visp is to raise awareness among compulsory school pupils and young people of innovation in the fields of mathematics, computer science, natural sciences and
Generate and sustain interest through hands-on workshops and experiments Read More »
Published today in the Bilan Magazine, discover the excellent overview written by Vincent Gilloz on the chemical-pharmaceutical sector good health. “The recent celebration of Valsynthèse’s 40th anniversary in Brigues, the ground-breaking ceremony for Debiopharm’s new building in Martigny and the inauguration of BioArk’s third center in Monthey are reminders of the sector’s excellent health in
Valais’ chemical-pharmaceutical sector in top form Read More »
One of the major events for virtual business development and licensing is back, from February 26 until March 1, 2024. As a partner of the event, BioArk is pleased to offer Valais life science actors a promo code to participate and enhance their business opportunities! The Biotechgate Digital Partnering virtual event is designed to support
Biotechgate Digital Partnering is back in February Read More »
As a resident of the BioArk technological site in Monthey, Stämm is pioneering innovations that redefine biomanufacturing. Their insights into Biomanufacturing 4.0 highlight a transformative approach that integrates cutting-edge technologies to enhance efficiency and sustainability.
Stämm’s Vision for Biomanufacturing 4.0 at BioArk Monthey Read More »
BioArk extend our very best Season’s Greetings for happiness, health and joy! We are looking forward to innovate with you in 2024.
Happy Holidays and best wishes for 2024 ! Read More »
👉 𝑵𝒂𝒗𝒊𝒈𝒂𝒕𝒊𝒏𝒈 𝒕𝒉𝒆 𝑫𝒊𝒈𝒊𝒕𝒂𝒍 𝑭𝒓𝒐𝒏𝒕𝒊𝒆𝒓: Highlights from a Day of Insightful Discourse on Digital Technologies in Biotech and Biopharma event on Campus Energypolis. It was an amazing opportunity to learn from experts and peers in the D-A-CH region about how digitalization, data science, artificial intelligence (AI), and machine learning (ML) are transforming biotechnology and biopharma.
Navigating the Digital Frontier Read More »
